Disclaimer: You are now leaving www.beiresources.org and are going to a website that is not operated by BEI Resources. We are not responsible for the content or availability of linked sites.
ABOUT THIRD PARTY LINKS ON OUR SITE:
BEI Resources offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links, you will leave the BEI Resources website and will be redirected to another site. These sites are not under the control of BEI Resources.
BEI Resources is not responsible for the content of linked third party websites. We are neither an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information.
Please read third party privacy and security policies closely as these may be different than BEI Resources policies.
If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.
History of the MR4
The Malaria Research and Reference Reagent Resource Center (MR4) was developed by the National Institute of Allergy and Infectious Diseases (NIAID) as an outgrowth of the Multilateral Initiative on Malaria (MIM), a federation of agencies involved in malaria research, control, and development assistance. At the International Conference on Malaria in Africa, held in Dakar in January, 1997, the issue of creating reagent repositories was raised. Specifically, scientists engaged in malaria research stated a need for: 1) improved access to parasite, vector, and human reagents; and 2) standardization of assays using well-characterized and renewable reagents.
In response to this stated need, NIAID made the commitment to establish a malaria reagent resource center for use by qualified investigators worldwide. A planning meeting was held in November, 1997, to gather ideas from investigators on how the new malaria resource center should function. A report and recommendations of the planning committee can be found in the archives of the NIAID Malaria website.
In September 1998, a seven-year contract was awarded to the American Type Culture Collection in Manassas, Virginia, to establish the Malaria Research and Reference Reagent Resource Center (MR4). This award includes a subcontract to the Centers for Disease Control Foundation to provide anopheline reagents. Funding for the MR4 was again awarded to ATCC in 2005 to grow and maintain the Resource Center, and over 600 laboratories worldwide have used the Resource Center. In January 2011, MR4 became part of the BEI Resources program.
An international Scientific Advisory Committee provides oversight of the MR4's operations, helps prioritize reagent acquisition and training needs, and acts as a liaison to the malaria community.
The purpose of the MR4 is to provide a centralized resource for research reagents to the scientific community that can be used as reference standards or to generate new renewable reagents. Generally speaking, reagents cannot be provided in bulk quantities. There is no charge for reagents. Types of reagents maintained by the Resource Center include:
Benefits to the Malaria Research Community
The benefits the MR4 provides to malaria research community investigators who deposit their materials in the collection are numerous. Through this program, MR4:
MR4 Registered User Benefits
The benefits the MR4 provides to malaria research community investigators who request materials through the repository program or utilize the resource center for information are numerous. Through this program, MR4:
Knowledge Base (FAQs)
Microsoft PowerPoint Viewer
Microsoft Word Viewer
Microsoft Excel Viewer
Call Us Toll-Free:(800) 359 - 7370
TTY:(703) 365 - 2727 (for deaf, hard of hearing, or speech impaired)